Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells

Blood

Volumn 119, Issue 12, 2012, Pages 2799-2809

  Simhadri, Venkateswara R ^a   Andersen, John F ^b   Calvo, Eric ^b   Choi, Seung Chul ^b   Coligan, John E ^b   Borrego, Francisco ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD 300A RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; LIGAND; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; HYDROPHILICITY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; ULTRACENTRIFUGATION;

EID: 84863386988     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-372425     Document Type: Article

References (50)

1. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science. 2000;290(5489):84-89.
2. Stanietsky N, Mandelboim O. Paired NK cell receptors controlling NK cytotoxicity. FEBS Lett. 2010;584(24):4895-4900.
3. Clark GJ, Ju X, Tate C, Hart DN. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 2009;30(5):209-217.
4. Martinez-Barriocanal A, Comas-Casellas E, Schwartz S, Jr., Martin M, Sayos J. CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J Biol Chem. 2010;285(53):41781-41794.
5. Lankry D, Simic H, Klieger Y, Levi-Schaffer F, Jonjic S, Mandelboim O. Expression and function of CD300 in NK cells. J Immunol. 2010;185(5): 2877-2886.
6. Nielsen R, Bustamante C, Clark AG, et al. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol. 2005;3(6): e170.
7. Alvarez Y, Tang X, Coligan JE, Borrego F. The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling. Mol Immunol. 2008;45(1):253-258. (Pubitemid 47331654)
8. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol. 2005;175(12):7989-7995. (Pubitemid 41798360)
9. Narayanan S, Silva R, Peruzzi G, et al. Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesodermin. PLoS One. 2010; 5(5):e10636.
10. Simhadri VR, Mariano JL, Zhou Q, Debell KE, Borrego F. Differential expression of CD300a/c on human TH1 and TH17 cells. BMC Immunol. 2011; 12:62.
11. Cantoni C, Bottino C, Augugliaro R, et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 1999;29(10):3148-3159. (Pubitemid 29484205)
12. Silva R, Moir S, Kardava L, et al. CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is downregulated in HIV infection. Blood. 2011;117(22): 5870-5880.
13. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood. 2006;107(5):1996-2003. (Pubitemid 43289383)
14. Speckman RA, Wright Daw JA, Helms C, et al. Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum Genet. 2003;112(1):34-41. (Pubitemid 36869113)
15. Burakoff R, Chao S, Perencevich M, et al. Bloodbased biomarkers can differentiate ulcerative colitis from crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis. 2011;17(8):1719- 1725.
16. Coustan-Smith E, Song G, Clark C, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011; 117(23):6267-6276.
17. Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol. 2006;118(5): 1082-1089. (Pubitemid 44666985)
18. Bachelet I, Munitz A, Levi-Schaffer F. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol. 2006;117(6):1314-1320. (Pubitemid 43795759)
19. Bachelet I, Munitz A, Berent-Maoz B, Mankuta D, Levi-Schaffer F. Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. J Immunol. 2008;180(9): 6064-6069.
20. Tang X, Narayanan S, Peruzzi G, et al. A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor- 1 with collagens. J Immunol. 2009;182(9): 5446-5452.
21. Balasubramanian K, Schroit AJ. Aminophospholipid asymmetry: A matter of life and death. Annu Rev Physiol. 2003;65:701-734. (Pubitemid 38249174)
22. Bratton DL, Henson PM. Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? Curr Biol. 2008;18(2):R76-79.
23. Ravichandran KS. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med. 2010;207(9):1807-1817.
24. Emoto K, Toyama-Sorimachi N, Karasuyama H, Inoue K, Umeda M. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res. 1997;232(2):430-434. (Pubitemid 27194059)
25. Maulik N, Kagan VE, Tyurin VA, Das DK. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol. 1998;274(1 Pt 2):H242-248.
26. Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res. 2008;49(7):1377-1387.
27. DeKruyff RH, Bu X, Ballesteros A, et al. T cell/ transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol. 2010;184(4):1918-1930.
28. Meers P, Mealy T. Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry. 1993;32(43):11711-11721. (Pubitemid 23341451)
29. Santiago C, Ballesteros A, Martinez-Munoz L, et al. Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds. Immunity. 2007;27(6):941-951. (Pubitemid 50013979)
30. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature. 2002;417(6885):182-187. (Pubitemid 34506799)
31. Zhao M, Li Z, Bugenhagen S. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. J Nucl Med. 2008;49(8): 1345-1352.
32. Kobayashi N, Karisola P, Pena-Cruz V, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927-940. (Pubitemid 50014866)
33. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidyl-serine receptor. Nature. 2007; 450(7168):435-439.
34. Dimasi N, Roessle M, Moran O, Candiano G, Svergun DI, Biassoni R. Molecular analysis and solution structure from small-angle X-ray scattering of the human natural killer inhibitory receptor IRp60 (CD300a). Int J Biol Macromol. 2007;40(3): 193-200. (Pubitemid 46223506)
35. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell. 2010; 140(5):619-630.
36. Krahling S, Callahan MK, Williamson P, Schlegel RA. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 1999;6(2): 183-189. (Pubitemid 29082307)
37. Ghosh S, Bell R. Liposomes. Applications in protein-lipid interaction studies. Methods Mol Biol. 2002;199:49-60.
38. Cannon JP, O'Driscoll M, Litman GW. Specific lipid recognition is a general feature of CD300 and TREM molecules. Immunogenetics. 2012; 64(1):39-47.
39. Kumagai H, Oki T, Tamitsu K, et al. Identification and characterization of a new pair of immunoglobulin- like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun. 2003;307(3):719-729. (Pubitemid 36944992)
40. Yotsumoto K, Okoshi Y, Shibuya K, et al. Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J Exp Med. 2003; 198(2):223-233. (Pubitemid 36987850)
41. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009;9(5):353-363.
42. Steevels TA, Meyaard L. Immune inhibitory receptors: essential regulators of phagocyte function. Eur J Immunol. 2011;41(3):575-587.
43. Park D, Tosello-Trampont AC, Elliott MR, et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature. 2007;450(7168):430-434. (Pubitemid 350126756)
44. Park SY, Jung MY, Kim HJ, et al. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 2008;15(1):192-201.
45. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008;8(5):327-336. (Pubitemid 351595219)
46. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol. 2003;4(1):87-91. (Pubitemid 36113217)
47. Choi SC, Simhadri VR, Tian L, et al. Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J Immunol. 2011;187(7):3483-3487.
48. Xi H, Katschke KJ, Jr., Helmy KY, et al. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J Exp Med. 2010; 207(1):7-16.
49. Dillon SR, Mancini M, Rosen A, Schlissel MS. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol. 2000;164(3):1322-1332. (Pubitemid 30067245)
50. Appelt U, Sheriff A, Gaipl US, Kalden JR, Voll RE, Herrmann M. Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ. 2005;12(2):194-196. (Pubitemid 40220651)